Stay updated on Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The revision indicator on the page was updated from v3.6.5 to v3.6.6, reflecting a newer site version.
    Difference
    0.1%
    Check dated 2026-08-29T20:32:29.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page changed from an error page to a full study record for NCT03498612, adding the study overview, design details, eligibility criteria, locations, outcomes, and links to related documents such as the Study Protocol and Statistical Analysis Plan.
    Difference
    52%
    Check dated 2026-08-15T18:48:55.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.6.5 replaces v3.6.4 on the page. This appears to be a small site maintenance update rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-08-08T15:37:37.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now shows a revised tag, updating from v3.6.3 to v3.6.4, indicating a minor site update. This does not alter study details or how the page operates.
    Difference
    0.1%
    Check dated 2026-07-25T07:38:53.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, representing a small update to the page metadata.
    Difference
    0.1%
    Check dated 2026-07-03T21:53:19.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.0 to v3.6.2, indicating an internal update to the page. This does not modify the displayed study information, eligibility criteria, or results.*
    Difference
    0.1%
    Check dated 2026-06-26T20:55:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.